XML 44 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements Of Cash Flows - USD ($)
12 Months Ended
Jul. 31, 2015
Jul. 31, 2014
Operating activities    
Net loss $ (7,627,000) $ (11,050,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 2,382,000 2,958,000
Amortization of stock issued for services 115,000 679,000
Stock issued under severance agreements   825,000
Stock issued to investors to amend subscription agreements   285,000
Settlement of vendor payables   182,000
Fair value of penalty warrants issued   23,000
Gain on extinguishment of debt   (727,000)
Gain on fixed asset sale   7,000
Stock issued for services   25,000
Warrants Issued For Services   121,000
Depreciation and amortization 206,000 248,000
Change in fair value of derivative liability (5,000) 55,000
Inventory reserve 0 128,000
Changes in operating assets and liabilities:    
Accounts receivable (142,000) (29,000)
Inventories 42,000 (12,000)
Restricted cash (75,000)  
Prepaid expenses   66,000
Accounts payable and accrued liabilities (955,000) (96,000)
Deferred rent (4,000)  
Net cash used in operating activities (6,063,000) (6,326,000)
Investing activities    
Investment in patents (26,000) (91,000)
Proceeds from sale of fixed assets   66,000
Purchases of property, plant and equipment (81,000) (21,000)
Net cash used in investing activities (107,000) (46,000)
Financing activities    
Net proceeds from the sale of common stock 7,401,000 6,617,000
Net proceeds from the exercise of warrants 4,000 337,000
Payment on note payable   (528,000)
Net cash provided by financing activities 7,405,000 6,426,000
Net increase in cash and cash equivalents 1,235,000 54,000
Cash and cash equivalents at beginning of period 86,000 32,000
Cash and cash equivalents at end of period 1,321,000 86,000
Supplemental disclosure of cash flow information    
Cash paid for taxes 1,600 4,000
Supplemental disclosure of non-cash investing and financing activities    
Common stock issued for prepaid services $ 206,000 175,000
Common stock issued in connection with financing   376,000
Settlement of warrant liability   97,000
Issuance of common stock for the cashless exercise of warrants   $ 1,000